Investigational Drugs List
Groups Distribution
Phase Distribution
Filter Conditions
Investigational Drugs List
| Drugs ID | CID | Drugs | Identifier | Molecular Formula | Molecular Weight | Groups | US Approved | Details |
|---|---|---|---|---|---|---|---|---|
| Drug161 | 118877516 | BMS-986166 | NCT03038711 | C25H33NO2 | 379.50 | NULL | NULL | Details |
| Drug162 | 118878093 | Brepocitinib | NCT02958865 | C18H21F2N7O | 389.40 | NULL | NULL | Details |
| Drug163 | 121299620 | Omilancor | NCT03861143 | C30H24N8O2 | 528.60 | NULL | NULL | Details |
| Drug164 | 121490254 | GED-0301 | NCT02601300, NCT02596893 | C200H261N69O107P20S20 | 6604.00 | NULL | NULL | Details |
| Drug165 | 121492440 | Cobitolimod | NCT01493960, NCT05404074, NCT04985968, NCT03178669 | C185H233N73O106P18S6 | 5925.00 | NULL | NULL | Details |
| Drug166 | 124090478 | Izencitinib | NCT03750565, NCT03408470, NCT04587713, NCT02818686, NCT03758443, NCT03920254 | C22H26N8 | 402.50 | NULL | NULL | Details |
| Drug167 | 124181541 | Tilpisertib | NCT04130919 | C33H33ClN8O | 593.10 | NULL | NO | Details |
| Drug168 | 129143185 | VTX002 | NCT05156125 | C21H13Cl3F3N5O3 | 546.70 | NULL | NULL | Details |
| Drug169 | 130298939 | SAR443122 | NCT05588843 | C19H18N6O3 | 378.40 | NULL | NO | Details |
| Drug170 | 130339268 | Ropsacitinib | NCT05225545 | C20H17N9 | 383.40 | NULL | NULL | Details |